JP2022518906A5 - - Google Patents

Info

Publication number
JP2022518906A5
JP2022518906A5 JP2021542541A JP2021542541A JP2022518906A5 JP 2022518906 A5 JP2022518906 A5 JP 2022518906A5 JP 2021542541 A JP2021542541 A JP 2021542541A JP 2021542541 A JP2021542541 A JP 2021542541A JP 2022518906 A5 JP2022518906 A5 JP 2022518906A5
Authority
JP
Japan
Application number
JP2021542541A
Other languages
Japanese (ja)
Other versions
JPWO2020159959A5 (https=
JP2022518906A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2020/015370 external-priority patent/WO2020159959A1/en
Publication of JP2022518906A publication Critical patent/JP2022518906A/ja
Publication of JPWO2020159959A5 publication Critical patent/JPWO2020159959A5/ja
Publication of JP2022518906A5 publication Critical patent/JP2022518906A5/ja
Priority to JP2023188791A priority Critical patent/JP2024039020A/ja
Priority to JP2025114666A priority patent/JP2025165933A/ja
Pending legal-status Critical Current

Links

JP2021542541A 2019-01-29 2020-01-28 サルカルディン塩 Pending JP2022518906A (ja)

Priority Applications (2)

Application Number Priority Date Filing Date Title
JP2023188791A JP2024039020A (ja) 2019-01-29 2023-11-02 サルカルディン塩
JP2025114666A JP2025165933A (ja) 2019-01-29 2025-07-07 サルカルディン塩

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US201962798467P 2019-01-29 2019-01-29
US62/798,467 2019-01-29
US202062959687P 2020-01-10 2020-01-10
US62/959,687 2020-01-10
PCT/US2020/015370 WO2020159959A1 (en) 2019-01-29 2020-01-28 Sulcardine salts

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2023188791A Division JP2024039020A (ja) 2019-01-29 2023-11-02 サルカルディン塩

Publications (3)

Publication Number Publication Date
JP2022518906A JP2022518906A (ja) 2022-03-17
JPWO2020159959A5 JPWO2020159959A5 (https=) 2022-10-31
JP2022518906A5 true JP2022518906A5 (https=) 2022-10-31

Family

ID=69724142

Family Applications (3)

Application Number Title Priority Date Filing Date
JP2021542541A Pending JP2022518906A (ja) 2019-01-29 2020-01-28 サルカルディン塩
JP2023188791A Pending JP2024039020A (ja) 2019-01-29 2023-11-02 サルカルディン塩
JP2025114666A Pending JP2025165933A (ja) 2019-01-29 2025-07-07 サルカルディン塩

Family Applications After (2)

Application Number Title Priority Date Filing Date
JP2023188791A Pending JP2024039020A (ja) 2019-01-29 2023-11-02 サルカルディン塩
JP2025114666A Pending JP2025165933A (ja) 2019-01-29 2025-07-07 サルカルディン塩

Country Status (16)

Country Link
US (3) US11426382B2 (https=)
EP (1) EP3917921A1 (https=)
JP (3) JP2022518906A (https=)
KR (2) KR102405199B1 (https=)
CN (2) CN115385871A (https=)
AU (1) AU2020216925B2 (https=)
BR (1) BR112021014640A8 (https=)
CA (1) CA3128152A1 (https=)
CL (1) CL2021001968A1 (https=)
CO (1) CO2021011042A2 (https=)
IL (1) IL285184B2 (https=)
MX (2) MX2021009033A (https=)
PH (1) PH12021551818A1 (https=)
SG (1) SG11202108160YA (https=)
WO (1) WO2020159959A1 (https=)
ZA (2) ZA202105344B (https=)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US11364223B2 (en) 2018-12-13 2022-06-21 Huyabio International, Llc Sulcardine administration for treatment of acute atrial fibrillation
CN115385871A (zh) * 2019-01-29 2022-11-25 沪亚生物国际有限公司 舒欣啶盐
CA3182015A1 (en) 2020-06-12 2021-12-16 Gary Elliott Sulcardine administration for treatment of acute atrial fibrillation

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1172908C (zh) * 1999-12-10 2004-10-27 中国科学院上海药物研究所 N-取代苄基或苯基芳香磺酰胺化合物及其用途
CN1299813C (zh) 2004-12-28 2007-02-14 华南理工大学 自动撕膜落料及多样性搅拌的机构和控制装置
CN1939298A (zh) * 2005-09-29 2007-04-04 中国科学院上海药物研究所 硫酸舒欣啶固体和靶向制剂及其制备方法
CN102665714A (zh) 2009-11-17 2012-09-12 沪亚生物国际有限责任公司 心房纤颤的治疗
EP2501380B1 (en) * 2009-11-17 2016-01-27 Huya Bioscience International LLC Slow infusion of sulcardine and its salts
MA41599A (fr) * 2015-02-26 2018-01-02 Array Biopharma Inc Formes cristallines d'un composé pyrrolopyridine
CA3254279A1 (en) 2015-06-03 2025-03-18 Triastek, Inc. PHARMACEUTICAL FORMS AND RELATED USES
CA3023278C (en) 2016-05-05 2019-04-30 Triastek, Inc. Controlled release dosage form
KR20190107712A (ko) 2017-01-26 2019-09-20 트리아스텍 인코포레이티드 특정 위장 부위에서의 제어 방출의 투여 형태
CA3054403A1 (en) * 2017-02-24 2018-08-30 Gilead Sciences, Inc. Inhibitors of bruton's tyrosine kinase
US11364223B2 (en) 2018-12-13 2022-06-21 Huyabio International, Llc Sulcardine administration for treatment of acute atrial fibrillation
CN115385871A (zh) 2019-01-29 2022-11-25 沪亚生物国际有限公司 舒欣啶盐

Similar Documents

Publication Publication Date Title
BR112023005462A2 (https=)
BR112023012656A2 (https=)
BR112021014123A2 (https=)
BR112023009656A2 (https=)
BR112022009896A2 (https=)
BR112021017747A2 (https=)
JP2022518906A5 (https=)
BR112022024743A2 (https=)
BR112022026905A2 (https=)
BR112023011738A2 (https=)
BR112023004146A2 (https=)
BR112023006729A2 (https=)
BR102021018859A2 (https=)
BR102021015500A2 (https=)
BR102020022030A2 (https=)
BR112023016292A2 (https=)
BR112023011539A2 (https=)
BR112023011610A2 (https=)
BR112023008976A2 (https=)
BR102021020147A2 (https=)
BR102021018926A2 (https=)
BR102021018167A2 (https=)
BR102021017576A2 (https=)
BR102021016837A2 (https=)
BR102021016551A2 (https=)